华西口腔医学杂志

• 临床研究 • 上一篇    下一篇

局部注射IL-2联合化疗对口腔鳞癌浸润淋巴细胞的影响

唐恩溢,胡勤刚,周炳荣,杨旭东   

  1. 210008 南京大学医学院附属口腔医院南京市口腔医院口腔颌面外科
  • 收稿日期:2003-12-25 修回日期:2003-12-25 出版日期:2003-12-20 发布日期:2003-12-20
  • 基金资助:

    本课题为南京市市级医学科技发展专项资金资助项目(编号 ZKG9818)

Effect of Local Immunotherapy of Interleukin 2(IL-2) in Combination with Chemotherapy upon Intratumoral Lympho- cytes in Oral Squamous Cell Carcinomas

TANG Enyi,HUQingang,ZHOUBingrong,et al.   

  1. Department ofOral andMaxillofacial Surgery,AffiliatedStomatologyHos- pital,Nanjing UniversityMedical School,Nanjing210008,China
  • Received:2003-12-25 Revised:2003-12-25 Online:2003-12-20 Published:2003-12-20

摘要:

目的 评价IL-2局部注射联合化疗对口腔鳞癌局部免疫反应的影响。方法 34例T3、T4期口腔鳞癌患者随机分成2组接受术前治疗,其中23例行免疫化疗(IL-2局部注射合并PVP化疗),11例行单纯化疗。比较 2组患者治疗前后肿瘤浸润T淋巴细胞亚群和B淋巴细胞的变化。结果 免疫化疗组治疗前后CD4+,CD8+, CD20+相对值分别为36·96,35·65,28·65和56·61,38·52,38·70。治疗后CD4+,CD20+细胞数较治疗前明显增加 (P<0·01)。单纯化疗组治疗前后CD4+,CD8+,CD20+细胞数均无显著差异(P>0·05)。结论 IL-2局部注射联合化疗对增强口腔鳞癌患者局部免疫功能具有重要意义。

关键词: 免疫化疗, 口腔鳞癌, 淋巴细胞

Abstract:

Objective To evaluate the effect of locoregional immunotherapy of interleukin 2 (IL-2) in combination with chemotherapy upon intratumoral lymphocytes in oral squamous cell carcinomas.Methods Thirty-four patientswith stageT3 orT4 oral squamous cell carcinoma were randomly divided into two groups, and treated with two therapies. 23 cases of them received immunochemotherapy and 11 cases received PVP chemotherapy. Changes ofT lymphocyte subsets and B cells at tumor site in the two groups were compared before and after therapy.Results The relative numbers of CD4+,CD8+,CD20+before and after treatment in immunochemotherapy were respectively 36.96, 35.65, 28.65 and 56.61,38.52,38.70. The numbers of CD4+, CD20+increased significantly after immunochemotherapy. However, in chemotherapy group, there was no significant difference in numbers of CD4+,CD8+and CD20+cells between pre and post treatment.Conclusion Immunochemotherapy for oral squamous cell carcinomas may play an important role in increasing local immunity.

Key words: immunochemotherapy, oral squamous cell carcinoma, lymphocyte